Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1103 | 968 | 1177 | 1266 | 1356 | 1618 |
Fund Return | 10.34% | -3.21% | 17.68% | 8.17% | 6.27% | 4.93% |
Place in category | 349 | 489 | 484 | 53 | 107 | 187 |
% in Category | 57 | 78 | 79 | 10 | 24 | 54 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
SSgA Luxembourg SICAV State Streewe | 5.28B | 18.75 | 8.48 | 11.23 | ||
State Street US Index EqI EUR Hdgd | 1.78B | 18.78 | 5.02 | 9.92 | ||
SSgA Luxembourg SICAV State Streete | 1.78B | 22.56 | 10.02 | 13.77 | ||
SSgA Enhanced EM Equity Fund I EUR | 672.72M | 16.07 | 2.69 | 5.71 | ||
State Street Europe Enhanced Equity | 327.96M | 8.90 | 5.49 | 6.49 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
United Kingdom Fund X2e | 197.88Array | 8.93 | 1.88 | 8.02 | ||
BlackRock UK Fund E2 EUR | 24.52M | 6.79 | -0.43 | 5.59 | ||
BlackRock Glbl Funds UK Fund A2 EUR | 96.04M | 7.23 | 0.07 | 6.12 | ||
BlackRock Glbl Funds UK Fund D2 EUR | 21.09M | 7.91 | 0.82 | 6.93 | ||
BlackRock Glbl Funds UK Fund C2 EUR | 3.8M | 6.11 | -1.18 | 4.81 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AstraZeneca | GB0009895292 | 9.84 | 10,474.0 | +4.09% | |
Shell | GB00BP6MXD84 | 9.34 | 31.61 | +0.25% | |
HSBC | GB0005405286 | 7.57 | 724.40 | -0.34% | |
Unilever | GB00B10RZP78 | 6.78 | 56.44 | +3.45% | |
Relx | GB00B2B0DG97 | 3.82 | 3,723.00 | +3.04% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Neutral | Buy |
Technical Indicators | Sell | Sell | Strong Buy |
Summary | Neutral | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review